Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

NCT00848211 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

OTHER: Placebo
BIOLOGICAL: TUTI-16 (0.03mg)
BIOLOGICAL: TUTI-16 (0.1mg)
BIOLOGICAL: TUTI-16 (0.6mg)

Sponsor

Thymon, LLC